The latest molecular experiments have offered several insights to the procedures that govern the development and progression of CLL, together with several novel mutated genes clustered in different functional pathways. The CLL epigenome is reprogrammed with the modulation of regulatory regions that show up de novoFirst chromosome banding Evaluation